{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:49:18Z","timestamp":1761630558100},"reference-count":42,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T00:00:00Z","timestamp":1205366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Purpose: <\/jats:bold> The natural history of primary biliary cirrhosis (PBC) has been little studied in Asia. We conducted a Taiwanese cohort study on the natural history of PBC and analysed the prognostic factors.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> This study enrolled 96 consecutive PBC patients between 1985 and 2006 to evaluate the baseline characteristics and outcomes.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> There were 74 females and 22 males. Eighty\u2010five were positive for antimitochondrial antibodies in sera, and 11 were negative. The clinical manifestations and prognosis were similar between these two groups. In a median follow\u2010up of 47.5\u00b155.8 months, 27 patients died. Multivariate analysis indicated that the independent prognostic factors were serum albumin (<jats:italic>P<\/jats:italic>=0.021), creatinine (<jats:italic>P<\/jats:italic>=0.033) and ursodeoxycholic acid treatment (<jats:italic>P<\/jats:italic>=0.008). Besides, 42 patients developed adverse outcomes. Albumin (<jats:italic>P<\/jats:italic>&lt;0.001), bilirubin (<jats:italic>P<\/jats:italic>=0.019) and prothrombin time (PT) (<jats:italic>P<\/jats:italic>=0.010) were significant factors. Moreover, a Mayo risk score &lt;5, a Model for End\u2010Stage Liver Disease (MELD) score &lt;6, a Child\u2013Pugh stage A and early liver histology were associated with favourable outcomes.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> Serum albumin, bilirubin and PT were independent prognostic factors of adverse outcomes for Taiwanese PBC patients. Besides, the Mayo risk score, the MELD score, the Child\u2013Pugh stage and liver histology were also validated to predict survival.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01715.x","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T13:28:59Z","timestamp":1282915739000},"page":"1305-1313","source":"Crossref","is-referenced-by-count":21,"title":["Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow\u2010up study up to 18 years"],"prefix":"10.1111","volume":"28","author":[{"given":"Chien\u2010Wei","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung\u2010Hsu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teh\u2010Ia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung\u2010Pin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han\u2010Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pui\u2010Ching","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou\u2010Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw\u2010Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,9,5]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5984"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13808-1"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043898"},{"key":"e_1_2_5_5_2","first-page":"1","article-title":"Prognosis in primary biliary cirrhosis","volume":"10","author":"Dickson ER","year":"1989","journal-title":"model for decision making"},{"key":"e_1_2_5_6_2","first-page":"1044","article-title":"Survival and symptom progression in a large cohort of patients with primary biliary cirrhosis","volume":"123","author":"Prince M","year":"2002","journal-title":"follow-up for up to 28 years"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.029"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21759"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290501"},{"key":"e_1_2_5_10_2","first-page":"1396","article-title":"Incidence of cancer in primary biliary cirrhosis","volume":"29","author":"Nijhawan PK","year":"1999","journal-title":"the Mayo experience"},{"key":"e_1_2_5_11_2","first-page":"1160","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis","volume":"96","author":"Caballeria L","year":"2001","journal-title":"similar incidence to that in hepatitis C virus-related cirrhosis"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.33157"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.09.031"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172"},{"key":"e_1_2_5_15_2","first-page":"470","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia","volume":"127","author":"Sood S","year":"2004","journal-title":"high prevalence in migrant populations"},{"key":"e_1_2_5_16_2","first-page":"494","article-title":"Clinical epidemiology of primary biliary cirrhosis","volume":"41","author":"Lazaridis KN","year":"2007","journal-title":"incidence, prevalence, and impact of therapy"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.50007.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1990.tb01441.x"},{"key":"e_1_2_5_19_2","first-page":"334","article-title":"Clinical evaluation of primary biliary cirrhosis in Chinese patients without serum anti\u2010mitochondrial antibody","volume":"59","author":"Li CP","year":"1997","journal-title":"Chin Med J"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05058.x"},{"key":"e_1_2_5_21_2","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Sheuer PJ.","year":"1967","journal-title":"Proc R Soc Med"},{"key":"e_1_2_5_22_2","first-page":"1208","article-title":"AASLD practice guideline","volume":"42","author":"Bruix J","year":"2005","journal-title":"management of hepatocellular carcinoma"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct074694"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01381.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250507"},{"key":"e_1_2_5_26_2","first-page":"30","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis in Japan","volume":"16","author":"Sakauchi F","year":"2006","journal-title":"utilization of clinical data when patients applied to receive public financial aid"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.7878"},{"key":"e_1_2_5_28_2","first-page":"659","article-title":"A sensitive bead assay for antimitochondrial antibodies","volume":"45","author":"Oertelt S","year":"2007","journal-title":"chipping away at AMA-negative primary biliary cirrhosis"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01078.x"},{"key":"e_1_2_5_30_2","first-page":"1046","article-title":"Rheumatic disorders and primary biliary cirrhosis","volume":"60","author":"Marasini B","year":"2001","journal-title":"an appraisal of 170 Italian patients"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50446"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.01.005"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.04.005"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.06.002"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2007.02.003"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.4.2651"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01291.x"},{"key":"e_1_2_5_38_2","first-page":"1053","article-title":"Randomised controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis","volume":"354","author":"Goulis J","year":"1999","journal-title":"a meta-analysis"},{"key":"e_1_2_5_39_2","first-page":"2063","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"97","author":"Papatheodoridis GV","year":"2002","journal-title":"final results of a 12-year, prospective, randomized, controlled trial"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04047.x"},{"key":"e_1_2_5_41_2","first-page":"1529","article-title":"Long\u2010term effects of mid\u2010dose ursodeoxycholic acid in primary biliary cirrhosis","volume":"101","author":"Shi J","year":"2006","journal-title":"a meta-analysis of randomized controlled trials"},{"key":"e_1_2_5_42_2","first-page":"1799","article-title":"Ursodeoxycholic acid for patients with primary biliary cirrhosis","volume":"102","author":"Gong Y","year":"2007","journal-title":"an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.009"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01715.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01715.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T16:07:56Z","timestamp":1697299676000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01715.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,5]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01715.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01715.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,5]]}}}